Apport de l’échelle nanométrique en thérapie photodynamique,la lumière à l’assaut du cancer:quoi de neuf?
Main Article Content
Abstract
Le développement d’un médicament efficace contre le cancer est l’un des plus grands défis de santé auxquels l’humanité est confrontée. Les effets secondaires indésirables de la chimiothérapie dans le traitement du can-cer ont incité les scientifiques à rechercher des traitements innovants et moins funestes. La photothérapie dynamique s’est imposée comme la meil-leure alternative pour s’éloigner des effets secondaires indésirables de la chimiothérapie.Cependant, la biomédecine s’oriente vers l’utilisation de-nanoparticules photosensibilisantes pour réduire les effets indésirables de cette technique. Cet article rappelle brièvement le principe de la thérapie photodynamique puis présente les dernières avancées en termes d’applica-tions cliniques.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
A- Open Access statement and license:
1-Open Access statement:
JFMO provides immediate open access to published content in support of the idea that free access to research helps support the dissemination of knowledge and ideas in the field of medical science. All articles will be published under Creative Commons licenses.
All published data is immediate free access to the work and permits any user to read, download, copy, distribute print, search, or link to the full texts of articles.
The users of any published material in the JFMO must act in accordance with the Creative Commons Licenses CC BY-NC-ND 4.0.
2-License:
All published data is distributed following the Creative Commons Licenses CC BY-NC-ND 4.0. This license is allowing others to download the works and share them with others as long as they correctly cite the manuscript, No changes are allowed to the original manuscript and the manuscript must be used only for non for profit or non-commercial purposes.
This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License.
3-Self Archiving:
Authors are permitted and encouraged to share online their articles published in JFMO (e.g., in institutional repositories or on their website), as it can lead to productive exchanges, as well as earlier and greater citation of published work.
